Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...
A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...
I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...
Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...
An Iowa girl battling cystic fibrosis is getting her dream trip, thanks to Make-A-Wish Iowa. Make-A-Wish Iowa and Hy-Vee surprised 8-year-old Aaliyah Peters with the trip on Friday. Aaliyah and her ...
Hosted on MSN5d
Glox to develop precision antibiotics for cystic fibrosisCollaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate ...
Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback